Kevin Puylaert, Chief Sales Officer at SOPHiA GENETICS SA (SOPH), sold 216 shares at $5.03 ($1K) on 2026-07-06, disclosed to the SEC on 2026-07-07.
Open-market sale of $1k SOPH by Chief Sales Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.03 | 47 | $236 | 21.7% |
| 2 | $5.03 | 138 | $693 | 63.8% |
| 3 | $5.09 | 31 | $158 | 14.5% |
| Total | $5.03 avg | 216 | $1K | 100% |
| Filing → |
| SOPH | SELL | 2026-04-21 | $168 | — | Filing → |
| SOPH | SELL | 2026-04-08 | $3K | — | Filing → |
| SOPH | SELL | 2026-04-01 | $14 | — | Filing → |